BHVN’s investment case definitely weakened after Opakalim’s Phase 2 MDD miss. This also means they’ll discontinue their ...
A wide-reaching new poll finds Americans are approaching 2026 with negative opinions about the economy, the direction of the ...
The dilapidated remains of a historic cabin shrouded by native trees and brush along the Wood River remain deeply rooted in ...
A new study finds that young adults squeezed by rent and cramped space reported higher activity levels, but also ...
Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain through electrodes that are placed on the scalp.
TrivarX (ASX: TRI) has delivered positive results from a US-based clinical trial that demonstrate clinically meaningful, ...
Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to ...
10d
A doctor who helped sell ketamine to actor Matthew Perry gets less than a year of home confinement
LOS ANGELES (AP) — A doctor who pleaded guilty in a scheme to supply ketamine to actor Matthew Perry was sentenced Tuesday to ...
The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...
While the coming recession should not rival the Great Depression, it is expected to be deeper and more prolonged than the ...
The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...
The US Food and Drug Administration (FDA) has cleared Flow Neuroscience’s at-home, non-drug depression treatment, making it the first device of its kind to gain clearance from the agency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback